• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妊娠期糖尿病女性的丁酰胆碱酯酶活性:与抗氧化活性的相关性

Butyrylcholinesterase activity in women with diabetes mellitus in pregnancy: correlation with antioxidant activity.

作者信息

Omu A E, Al-Azemi M K, Omu F E, Fatinikun T, Abraham S, George S, Mahnazhath N

机构信息

Department of Obstetrics and Gynaecology, Faculty of Medicine, Kuwait University, Safat, Kuwait.

出版信息

J Obstet Gynaecol. 2010 Feb;30(2):122-6. doi: 10.3109/01443610903443913.

DOI:10.3109/01443610903443913
PMID:20143968
Abstract

A total of: 25 women with gestational diabetes, 25 with type 2 diabetes, 21 with healthy pregnancies and 15 non-pregnant healthy controls were investigated to evaluate the relationship between butyrylcholinesterase activity and antioxidant status in the serum and placenta of diabetic pregnant women. Levels of antioxidant activities were estimated by Randox Kits and malondialdehyde and butyrylcholinesterase by colorimetric methods. Butyrylcholinesterase activity was elevated in the serum and placenta in normal pregnancy vs diabetic cohorts (p < 0.01) and there was a higher activity level in gestational and type 2 diabetes on insulin (p < 0.05) compared with diet controlled. There was higher malondialdehyde and lower antioxidant activity in diet vs insulin controlled diabetes (p < 0.01). Serum and placental butyrylcholinesterase activity showed a strong inverse correlation with malondialdehyde (r = -0.876, p < 0.001) and (r = 0.542, p < 0.01), but strong positive correlation with total antioxidant activity in serum (r = 0.764, p < 0.001) and placenta (r = 0.642, p < 0.01). Butyrylcholinesterase may therefore, be involved in reducing oxidative stress in diabetic pregnancy.

摘要

总共对25名妊娠糖尿病女性、25名2型糖尿病女性、21名正常妊娠女性和15名非妊娠健康对照者进行了调查,以评估糖尿病孕妇血清和胎盘中丁酰胆碱酯酶活性与抗氧化状态之间的关系。抗氧化活性水平通过兰多克斯试剂盒进行评估,丙二醛和丁酰胆碱酯酶通过比色法进行测定。与糖尿病组相比,正常妊娠组血清和胎盘中的丁酰胆碱酯酶活性升高(p < 0.01),与饮食控制相比,妊娠糖尿病和2型糖尿病患者使用胰岛素时的活性水平更高(p < 0.05)。饮食控制的糖尿病患者与胰岛素控制的糖尿病患者相比,丙二醛水平更高,抗氧化活性更低(p < 0.01)。血清和胎盘丁酰胆碱酯酶活性与丙二醛呈强烈负相关(r = -0.876,p < 0.001)和(r = 0.542,p < 0.01),但与血清(r = 0.764,p < 0.001)和胎盘(r = 0.642,p < 0.01)中的总抗氧化活性呈强烈正相关。因此,丁酰胆碱酯酶可能参与减轻糖尿病妊娠中的氧化应激。

相似文献

1
Butyrylcholinesterase activity in women with diabetes mellitus in pregnancy: correlation with antioxidant activity.妊娠期糖尿病女性的丁酰胆碱酯酶活性:与抗氧化活性的相关性
J Obstet Gynaecol. 2010 Feb;30(2):122-6. doi: 10.3109/01443610903443913.
2
Changes in plasma lipids and markers of oxidative stress in normal pregnancy and pregnancies complicated by diabetes.正常妊娠及合并糖尿病妊娠时血浆脂质及氧化应激标志物的变化。
Clin Sci (Lond). 2004 Jan;106(1):93-8. doi: 10.1042/CS20030175.
3
Lipid peroxidation, antioxidant defense, status of trace metals and leptin levels in preeclampsia.子痫前期患者的脂质过氧化、抗氧化防御、微量金属状态及瘦素水平
Eur J Obstet Gynecol Reprod Biol. 2005 Mar 1;119(1):60-6. doi: 10.1016/j.ejogrb.2004.06.033.
4
[Glucooxidative stress and spontaneous abortion in pregnant women with diabetes mellitus type 1].[1型糖尿病孕妇的糖氧化应激与自然流产]
Akush Ginekol (Sofiia). 2005;44(4):3-10.
5
Oxidative and antioxidative status in pregnant women with either gestational or type 1 diabetes.患有妊娠期糖尿病或1型糖尿病的孕妇的氧化和抗氧化状态。
Clin Biochem. 2004 Apr;37(4):293-8. doi: 10.1016/j.clinbiochem.2003.12.005.
6
[Evaluation of lipid peroxidation and acid-base status in cord blood of newborns after diabetes in pregnancy].
Przegl Lek. 2001;58(3):120-3.
7
Oxidative stress status in patients with diabetes mellitus: relationship to diet.糖尿病患者的氧化应激状态:与饮食的关系
Eur J Clin Nutr. 2003 Aug;57(8):999-1008. doi: 10.1038/sj.ejcn.1601635.
8
Malondialdehyde, glutathione, glutathione peroxidase and homocysteine levels in type 2 diabetic patients with and without microalbuminuria.2型糖尿病伴和不伴微量白蛋白尿患者的丙二醛、谷胱甘肽、谷胱甘肽过氧化物酶和同型半胱氨酸水平。
Ann Clin Biochem. 2005 Mar;42(Pt 2):99-104. doi: 10.1258/0004563053492838.
9
Fetomaternal adrenomedullin levels in diabetic pregnancy.
Horm Metab Res. 2001 Aug;33(8):486-90. doi: 10.1055/s-2001-16942.
10
The incidence of placental abnormalities, maternal and cord plasma malondialdehyde and vascular endothelial growth factor levels in women with gestational diabetes mellitus and nondiabetic controls.妊娠期糖尿病女性和非糖尿病对照组中胎盘异常的发生率、母体及脐带血浆丙二醛和血管内皮生长因子水平
Gynecol Obstet Invest. 2008;65(4):227-32. doi: 10.1159/000113045. Epub 2008 Jan 14.

引用本文的文献

1
Alterations in acetylcholinesterase and butyrylcholinesterase activities in chronic obstructive pulmonary disease: relationships with oxidative and inflammatory markers.慢性阻塞性肺疾病中乙酰胆碱酯酶和丁酰胆碱酯酶活性的改变:与氧化和炎症标志物的关系。
Mol Cell Biochem. 2018 Aug;445(1-2):1-11. doi: 10.1007/s11010-017-3246-z. Epub 2017 Dec 12.
2
Assessment of platelets morphological changes and serum butyrylcholinesterase activity in children with diabetic ketoacidosis: a case control study.糖尿病酮症酸中毒患儿血小板形态变化及血清丁酰胆碱酯酶活性评估:一项病例对照研究。
BMC Endocr Disord. 2017 Apr 4;17(1):23. doi: 10.1186/s12902-017-0174-6.
3
Effect of Acetylcholinesterase and Butyrylcholinesterase on Intrauterine Insemination, Contribution to Inflammations, Oxidative Stress and Antioxidant Status; A Preliminary Report.
乙酰胆碱酯酶和丁酰胆碱酯酶对宫腔内人工授精的影响、对炎症、氧化应激和抗氧化状态的作用;初步报告
J Reprod Infertil. 2016 Jul-Sep;17(3):157-62.
4
Agrimonia eupatoria L. and Cynara cardunculus L. Water Infusions: Comparison of Anti-Diabetic Activities.龙芽草和菜蓟水浸液:抗糖尿病活性比较
Molecules. 2016 Apr 28;21(5):564. doi: 10.3390/molecules21050564.
5
Gestational diabetes mellitus (GDM) decreases butyrylcholinesterase (BChE) activity and changes its relationship with lipids.妊娠糖尿病(GDM)会降低丁酰胆碱酯酶(BChE)的活性,并改变其与脂质的关系。
Genet Mol Biol. 2014 Mar;37(1):1-6. doi: 10.1590/s1415-47572014000100003. Epub 2013 Feb 28.
6
Influence of obstructive sleep apnea on serum butyrylcholinesterase activity and ischemia-modified albumin levels.阻塞性睡眠呼吸暂停对血清丁酰胆碱酯酶活性和缺血修饰白蛋白水平的影响。
Clinics (Sao Paulo). 2013 Jul;68(7):968-73. doi: 10.6061/clinics/2013(07)13.